![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Spectrum Acquires Worldwide License to EndothelinB Agonists
Spectrum Acquires Worldwide License to EndothelinB Agonists
Spectrum Pharmaceuticals announced that it has acquired
an exclusive worldwide license to develop and commercialize endothelinB agonists
for the treatment of cancer, including treatment of solid tumors, from Chicago
Labs Inc., a privately held company. Chicago Labs licensed the technology and
related patents from the University of Illinois.
Yahoo
News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct